2The sixth report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure. Arch Intern Med,1997,157: 2413-2446.
3Gifford RW Jr. An Algorithm for the management of resistant hypertension. Hypertension, 1988.11 ( 3 Pt 2) : II101-II105.
4Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens, 2001,14 : 1263-1269.
5Lake CR, Gallant S, Masson E, et al. Adverse drug effects attributed to phenypropanolamine ( PPA ). A review of 142 case reports. Am J Med. 1990.89:195-198.
6Black HR. Management of patients with refractory hypertension. In:Izzo JL, Black,ed. Hypertension Primer. Second Edition. Am Heart Association Chapter, 1999. 123,354-357.
7Morimoto S, Sasaki S. Lopemmide therapy in a patient with diarrhea and resistant hypertension. Am J Hypertens,2000, 13 : 431-432.
8Kaplan NM. Anxiety-induced hypertension. A common cause of symptoms in patients with hypertension. Arch Intern Med, 1997,157: 945-948.
9Klassen PS. Diagnosis and management of renovaseular hypertension. Cardiol Rev,2000,8 : 17 -30.
10Rayner BL, Opie LH, Davidson TS, et al. The aldosteronism/renin ratio as screening test for primary aldosteronism. SAMH, 2000,90:394-400.
二级参考文献3
1Rayner BL,Opie LH,Davidson JS.The aldosterone/renin ratio as screening test for primary aldosteronism[].SAMH.2000
2Lim PO,Young WF,Maedonald TM.A review of the medical treatment of primary aldosteronism[].Journal of Hypertension.2001
3Lim OP,Dow E,Brennan G,et al.High prevalence of primary aldosteronism in the Tayside hypertension clinic population[].Journal of Human Hypertension.2000
